Atlas Trials

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00003301 · COMPLETED

Trial details

NCT number
NCT00003301
Sponsor
New Approaches to Brain Tumor Therapy Consortium
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Brain and Central Nervous System Tumors
Start date
1998-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.